Georges Jourdi
LightNews LightNews
banner
gjourdi.bsky.social
Georges Jourdi
@gjourdi.bsky.social
110 followers 110 following 4 posts
Posts Replies Media Videos
Reposted by Georges Jourdi
dianvanderwaldr.bsky.social
Join us in the #platelets physiology session at 14.30pm in room 152a.
We're talking about flow cytometry, future in diagnostics and dense granules
@gjourdi.bsky.social @alexkzis.bsky.social #isth2025
a girl is pushing a trolley with a child in it
ALT: a girl is pushing a trolley with a child in it
media.tenor.com
June 21, 2025 at 12:50 PM
gjourdi.bsky.social
Let’s the amazing meetings, presentations and scientific discussions begin! Fully ready for the start @isth.org #isth2025
June 20, 2025 at 9:45 AM
gjourdi.bsky.social
Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening - Journal of Thrombosis and Haemostasis www.jthjournal.org/article/S153...
Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening
Although heritability of venous thromboembolism (VTE) is high, the thrombophilia screening appears to be positive only in a minority of VTE patients. Adding rare variants screening to identify VTE mis...
www.jthjournal.org
January 29, 2025 at 6:50 PM
gjourdi.bsky.social
www.nejm.org/doi/full/10....
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation | NEJM
Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation. The safety of abelacimab as compared with a direct oral anticoagulant in pati...
www.nejm.org
January 23, 2025 at 10:34 PM
Reposted by Georges Jourdi
sfthemostase.bsky.social
La Société Française de Thrombose et d’Hémostase (SFTH) est désormais sur Bluesky ! 🌟 Rejoignez-nous pour échanger autour de l’hémostase, de la thrombose et de l’innovation scientifique. Suivez-nous pour rester informés de nos actualités et événements ! 🩸💬 #SFTH #Thrombose #Hémostase #Medsky
January 14, 2025 at 2:41 PM
gjourdi.bsky.social
#ISTH2026 🇫🇷
December 6, 2024 at 5:48 AM
Reposted by Georges Jourdi
profmakris.bsky.social
Excellent short commentary in the journal Blood about the prospective Austrian study examining bleeding in cancer patients. The rates of bleeding observed were higher than the placebo arms of anticoagulation in cancer studies. #Cancer #bleeding
November 28, 2024 at 7:34 PM